Tactic Pharma LLC

Related company / holding

Insider activity · 24 months0 buys2 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 1 saleMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 1 saleOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (2 ops.)

€30.9M

Latest filing published 26 Sept 2025 for Monopar Therapeutics, €29.8M. Read the official filing

Filing timeline

BuySale

Tactic Pharma LLC

Insider track record

Disclosed buys

Disclosed sells

Signal history

Tactic Pharma LLC: trading record in brief

Tactic Pharma LLC appears in our data through filings on Monopar Therapeutics shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 2 April 2025 and the latest from 24 September 2025.

The open-market record consists of 2 sales worth €30.9M, with no purchase.

The record was last updated on 26 September 2025 with an open-market sale (€29.8M) in Monopar Therapeutics. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.